Azenta Other Long-Term Assets 2010-2025 | AZTA
Azenta other long-term assets from 2010 to 2025. Other long-term assets can be defined as field containing the sum of all non-current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
| Azenta Annual Other Long-Term Assets (Millions of US $) |
|
|---|---|
| 2024 | $11 |
| 2023 | $4 |
| 2022 | $57 |
| 2021 | $242 |
| 2020 | $149 |
| 2019 | $21 |
| 2018 | $64 |
| 2017 | $63 |
| 2016 | $40 |
| 2015 | $9 |
| 2014 | $5 |
| 2013 | $7 |
| 2012 | $6 |
| 2011 | $3 |
| 2010 | $3 |
| 2009 | $3 |
| Azenta Quarterly Other Long-Term Assets (Millions of US $) |
|
|---|---|
| 2025-03-31 | $148 |
| 2024-12-31 | $168 |
| 2024-09-30 | $184 |
| 2024-06-30 | $77 |
| 2024-03-31 | $10 |
| 2023-12-31 | $77 |
| 2023-09-30 | $4 |
| 2023-06-30 | $72 |
| 2023-03-31 | $68 |
| 2022-12-31 | $62 |
| 2022-09-30 | $57 |
| 2022-06-30 | $53 |
| 2022-03-31 | $65 |
| 2021-12-31 | $246 |
| 2021-09-30 | $242 |
| 2021-06-30 | $85 |
| 2021-03-31 | $71 |
| 2020-12-31 | $72 |
| 2020-09-30 | $149 |
| 2020-06-30 | $57 |
| 2020-03-31 | $56 |
| 2019-12-31 | $49 |
| 2019-09-30 | $21 |
| 2019-06-30 | $87 |
| 2019-03-31 | $86 |
| 2018-12-31 | $84 |
| 2018-09-30 | $64 |
| 2018-06-30 | $6 |
| 2018-03-31 | $6 |
| 2017-12-31 | $6 |
| 2017-09-30 | $63 |
| 2017-06-30 | $6 |
| 2017-03-31 | $6 |
| 2016-12-31 | $5 |
| 2016-09-30 | $40 |
| 2016-06-30 | $13 |
| 2016-03-31 | $10 |
| 2015-12-31 | $10 |
| 2015-09-30 | $9 |
| 2015-06-30 | $9 |
| 2015-03-31 | $9 |
| 2014-12-31 | $7 |
| 2014-09-30 | $5 |
| 2014-06-30 | $5 |
| 2014-03-31 | $8 |
| 2013-12-31 | $7 |
| 2013-09-30 | $7 |
| 2013-06-30 | $10 |
| 2013-03-31 | $9 |
| 2012-12-31 | $7 |
| 2012-09-30 | $6 |
| 2012-06-30 | $6 |
| 2012-03-31 | $3 |
| 2011-12-31 | $3 |
| 2011-09-30 | $3 |
| 2011-06-30 | $3 |
| 2011-03-31 | $3 |
| 2010-12-31 | $3 |
| 2010-09-30 | $3 |
| 2010-06-30 | $3 |
| 2010-03-31 | $3 |
| 2009-12-31 | $3 |
| 2009-09-30 | $3 |
| 2009-06-30 | $4 |
| 2009-03-31 | $3 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.562B | $0.656B |
| Azenta Inc. is a provider of life sciences solutions. The company provides reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the pharmaceutical, biotech, academic and healthcare institutions. Azenta Inc., formerly known as Brooks Automation Inc., is based in CHELMSFORD, Mass. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $47.813B | 60.83 |
| Hims & Hers Health (HIMS) | United States | $13.134B | 136.46 |
| Doximity (DOCS) | United States | $11.457B | 53.04 |
| Tempus AI (TEM) | United States | $10.733B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.377B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.856B | 60.24 |
| Hinge Health (HNGE) | United States | $3.535B | 0.00 |
| Privia Health (PRVA) | United States | $2.402B | 164.17 |
| 10x Genomics (TXG) | United States | $1.803B | 0.00 |
| Schrodinger (SDGR) | United States | $1.643B | 0.00 |
| Phreesia (PHR) | United States | $1.614B | 0.00 |
| Enovis (ENOV) | United States | $1.561B | 8.70 |
| Clover Health Investments (CLOV) | United States | $1.527B | 0.00 |
| Omnicell (OMCL) | United States | $1.358B | 23.97 |
| Evolent Health (EVH) | United States | $1.133B | 96.50 |
| Claritev (CTEV) | United States | $0.664B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.549B | 0.00 |
| Standard BioTools (LAB) | United States | $0.539B | 0.00 |
| Veradigm (MDRX) | United States | $0.507B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.480B | 0.00 |
| Talkspace (TALK) | United States | $0.428B | 128.00 |
| TruBridge (TBRG) | United States | $0.347B | 771.00 |
| Outset Medical (OM) | United States | $0.320B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.285B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.244B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.224B | 0.00 |
| CapsoVision (CV) | United States | $0.202B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.199B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.157B | 0.00 |
| American Well (AMWL) | United States | $0.136B | 0.00 |
| Pulmonx (LUNG) | United States | $0.124B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.123B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.120B | 0.00 |
| CareCloud (CCLD) | United States | $0.104B | 3.95 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.092B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.080B | 0.00 |
| 111 (YI) | China | $0.061B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.050B | 0.00 |
| HeartBeam (BEAT) | United States | $0.043B | 0.00 |
| Zhongchao (ZCMD) | China | $0.026B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| PROFUSA (PFSA) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |